menu
    • menu

    Company profile for 3S Bio Inc

    NEW Drugs in Dev: 3
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    3SBio Group has always been committed to solving the problem of clinical drug use for patients, constantly conquering the challenges of the disease, using high-quality drugs to improve the quality of life of patients, and working hard for the benefit of human health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    3S Bio IncChina Flag
    Country
    Country
    China
    Address
    Address
    1st 3, 10th Road, Economic and Technological Development Zone, Shenyang
    Telephone
    Telephone
    +86 024 2538 6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.3sbio.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    3SBio 2025 Results: Revenue Tops RMB-10B on R&D & Deals
    3SBio 2025 Results: Revenue Tops RMB-10B on R&D & Deals

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/3sbio-announces-2025-annual-results-dual-engines-of-innovative-rd-and-global-collaboration-propel-revenue-past-rmb-10-billion-milestone-302729331.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Pfizer Completes Licensing Agreement with 3SBio
    Pfizer Completes Licensing Agreement with 3SBio

    26 Jul 2025

    // PRESS RELEASE

    https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-licensing-agreement-3sbio

    PRESS RELEASE
    26 Jul 2025
    Share Share
    Pfizer in deal with China's 3SBio to license cancer drug candidate
    Pfizer in deal with China's 3SBio to license cancer drug candidate

    20 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-signs-up-6-billion-licensing-deal-with-chinas-3sbio-cancer-drug-2025-05-20/

    REUTERS
    20 May 2025
    Share Share
    3SBio announces 2021 interim results, with strong growth in core businesses
    3SBio announces 2021 interim results, with strong growth in core businesses

    26 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/3sbio-announces-2021-interim-results-with-strong-growth-in-core-businesses-and-significant-progress-in-clinical-development-301363680.html

    PRNEWSWIRE
    26 Aug 2021
    Share Share
    Sorrento and 3SBio Announce CAR-T Joint Venture in China
    Sorrento and 3SBio Announce CAR-T Joint Venture in China

    07 Jun 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/sorrento-and-3sbio-announce-car-t-joint-venture-in-china-300280830.html

    PR NEWSWIRE
    07 Jun 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search